DK2245463T3 - Diagnostisk fremgangsmåde - Google Patents
Diagnostisk fremgangsmådeInfo
- Publication number
- DK2245463T3 DK2245463T3 DK09709860.2T DK09709860T DK2245463T3 DK 2245463 T3 DK2245463 T3 DK 2245463T3 DK 09709860 T DK09709860 T DK 09709860T DK 2245463 T3 DK2245463 T3 DK 2245463T3
- Authority
- DK
- Denmark
- Prior art keywords
- diagnostic procedure
- diagnostic
- procedure
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biophysics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0802851.6A GB0802851D0 (en) | 2008-02-15 | 2008-02-15 | Diagnostic method |
PCT/EP2009/001210 WO2009100953A2 (en) | 2008-02-15 | 2009-02-13 | Diagnostic method |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2245463T3 true DK2245463T3 (da) | 2014-04-07 |
Family
ID=39271801
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK09709860.2T DK2245463T3 (da) | 2008-02-15 | 2009-02-13 | Diagnostisk fremgangsmåde |
Country Status (7)
Country | Link |
---|---|
US (4) | US9625474B2 (da) |
EP (1) | EP2245463B1 (da) |
DK (1) | DK2245463T3 (da) |
ES (1) | ES2455216T3 (da) |
GB (1) | GB0802851D0 (da) |
PL (1) | PL2245463T3 (da) |
WO (1) | WO2009100953A2 (da) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014071359A1 (en) * | 2012-11-05 | 2014-05-08 | Msdx, Inc. | Detection of neurological diseases via measurement of neuromelanin in recirculating phagocytes |
GB0802851D0 (en) | 2008-02-15 | 2008-03-26 | Medinnova As | Diagnostic method |
CA2818171A1 (en) * | 2010-11-24 | 2012-06-07 | Elan Pharmaceuticals, Inc. | Phagocytic activity as a marker of synucleinopathic disease |
EP2495567A1 (en) * | 2011-03-04 | 2012-09-05 | Erasmus University Medical Center Rotterdam | Methods and means for monitoring disruption of tissue homeostasis in the total body |
WO2016137947A1 (en) | 2015-02-24 | 2016-09-01 | Rpeptide, Llc | Anti-amyloid-beta antibodies |
US11142570B2 (en) | 2017-02-17 | 2021-10-12 | Bristol-Myers Squibb Company | Antibodies to alpha-synuclein and uses thereof |
JP7194926B2 (ja) * | 2018-06-28 | 2022-12-23 | 東亞合成株式会社 | 3大神経変性疾患の診断補助方法 |
AU2022233849A1 (en) | 2021-03-08 | 2023-10-12 | Akershus Universitetssykehus Hf | Clearance assay |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0885392B1 (de) | 1996-03-06 | 2002-02-06 | Manfred Hartwig | Differentialdianostisches verfahren zum nachweis verschiedener stadien der alzheimer-krankheit |
US7687231B2 (en) * | 2006-01-30 | 2010-03-30 | Yamasa Corporation | Method for determining degree of negative effect of macrophages on vertebrate |
GB0802851D0 (en) | 2008-02-15 | 2008-03-26 | Medinnova As | Diagnostic method |
AU2009295357A1 (en) | 2008-09-26 | 2010-04-01 | The University Of Melbourne | Alzheimer's disease biomarkers |
-
2008
- 2008-02-15 GB GBGB0802851.6A patent/GB0802851D0/en not_active Ceased
-
2009
- 2009-02-13 EP EP09709860.2A patent/EP2245463B1/en active Active
- 2009-02-13 ES ES09709860.2T patent/ES2455216T3/es active Active
- 2009-02-13 PL PL09709860T patent/PL2245463T3/pl unknown
- 2009-02-13 DK DK09709860.2T patent/DK2245463T3/da active
- 2009-02-13 WO PCT/EP2009/001210 patent/WO2009100953A2/en active Application Filing
- 2009-02-13 US US12/867,479 patent/US9625474B2/en active Active
-
2017
- 2017-03-30 US US15/474,231 patent/US10281477B2/en active Active
-
2019
- 2019-03-15 US US16/355,661 patent/US20190204343A1/en not_active Abandoned
-
2020
- 2020-12-03 US US17/110,512 patent/US20210109114A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ES2455216T3 (es) | 2014-04-15 |
US20170307632A1 (en) | 2017-10-26 |
US10281477B2 (en) | 2019-05-07 |
WO2009100953A3 (en) | 2009-11-05 |
US20110124010A1 (en) | 2011-05-26 |
US20210109114A1 (en) | 2021-04-15 |
WO2009100953A2 (en) | 2009-08-20 |
US20180067127A9 (en) | 2018-03-08 |
EP2245463A2 (en) | 2010-11-03 |
GB0802851D0 (en) | 2008-03-26 |
US20190204343A1 (en) | 2019-07-04 |
US9625474B2 (en) | 2017-04-18 |
EP2245463B1 (en) | 2014-01-01 |
PL2245463T3 (pl) | 2014-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0921327A2 (pt) | Combinação de herbicida-protetor | |
BRPI0907376A2 (pt) | Fotobiorretador | |
DK2342317T3 (da) | Hængende-dråbe-plade | |
DE602009000234D1 (de) | msignals | |
DE602009000580D1 (de) | Endoskopsystem | |
BRPI0914649A2 (pt) | Piprazolo-quinazolinas | |
DE602008003972D1 (de) | Sitzrücklehnungsmechanismus | |
FIC20240018I1 (fi) | Vamoroloni | |
DE602008003521D1 (de) | Sitzrücklehnungsmechanismus | |
DK2336132T3 (da) | Morpholinpurinderivat | |
DE102009035941B8 (de) | Diagnostiksystem | |
DK2335031T3 (da) | In-line-måler | |
DK2837348T3 (da) | Kryokirurgiske fremgangsmåder | |
DK2318650T3 (da) | Kompletteringsaggregat | |
DE602008003970D1 (de) | Strahlstromkalibriersystem | |
BRPI0915822A2 (pt) | dispositivo médico | |
DK2271613T3 (da) | Hydroxymethylcyklohexylaminer | |
BRPI0907522A2 (pt) | biarlamidas | |
BRPI0909634A2 (pt) | 2-aminoquinolinas | |
DE112009000183A5 (de) | Sicherheitsvorreiber | |
BRPI0922728A2 (pt) | combinação de herbicida-antídoto | |
DE112009001946A5 (de) | Mobelauszugsführung | |
DE602009000488D1 (de) | Obstvereinzelvorrichtung | |
DK2245463T3 (da) | Diagnostisk fremgangsmåde | |
BRPI0907863A2 (pt) | pirrolopirimidinacarboxamidas |